BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted)
HIPRA-HH-17
Approved small_molecule active
Quick answer
BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted) for COVID-19 is a Approved program (small_molecule) at Hipra Human Health S.L. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Hipra Human Health S.L.
- Indication
- COVID-19
- Phase
- Approved
- Modality
- small_molecule
- Status
- active